Deleterious variants in two other genes, CFAP45/CCDC19/NESG1, and CFAP52/WDR16, have been found in human individuals whose clinical presentation, with situs inversus and asthenozoospermia, but only mild respiratory symptoms, did not allow for classifying them as classical PCD cases [151]. This evidence concerns the gene CFAP52 and situs inversus.